TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Takeover

  • If you are a current investor in ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) shares and purchased your NASDAQ:ISTA shares prior to March 26, 2012, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

San Diego, March 26, 2012 (Shareholders Foundation) -- The announcement by ISTA Pharmaceuticals, Inc. that its board of directors agreed a takeover of ISTA Pharmaceuticals, Inc. by Bausch + Lomb for $9.10 per NASDAQ:ISTA share prompted an investigation for investors in ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA) shares concerning whether the offer to acquire ISTA Pharmaceuticals, Inc. an...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: